Encompass Health Issues Notice for Partial Redemption of Its 5.75% Senior Notes Due 2025

Rhea-AI Summary

Encompass Health (NYSE: EHC) has announced the partial redemption of its 5.75% senior notes due 2025. The company will redeem $100 million of the outstanding principal balance, with the redemption date set for November 21, 2024. The redemption price will be 100.0% of par, plus accrued and unpaid interest as per the terms of the 2025 Notes.

Encompass Health plans to use cash on hand to fund this redemption. As a result of this action, the company anticipates recording an approximate $0.2 million loss on early extinguishment of debt in the fourth quarter of 2024.

Positive

• Partial redemption of debt indicates strong cash position
• Redemption at par value (100.0%) suggests favorable financial terms
• Use of cash on hand for redemption demonstrates liquidity strength

Negative

• Expected $0.2 million loss on early extinguishment of debt in Q4 2024

BIRMINGHAM, Ala., Oct. 22, 2024 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of $100 million of the outstanding principal balance of its 5.75% senior notes due 2025 (the "2025 Notes"). The associated redemption date will be November 21, 2024, and the redemption price will be 100.0% of par, plus accrued and unpaid interest pursuant to the terms of the 2025 Notes. The Company plans to use cash on hand to fund the redemption. As a result of this redemption, the Company expects to record an approximate $0.2 million loss on early extinguishment of debt in the fourth quarter of 2024.

About Encompass Health
Encompass Health (NYSE: EHC) is the largest owner and operator of rehabilitation hospitals in the United States. With a national footprint that includes 165 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies and Becker's Hospital Review's 150 Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.

Forward-Looking Statements
Statements contained in this press release which are not historical facts are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant market disruption; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2023 and Forms 10-Q for the quarters ended Mar. 31, 2024 and Jun. 30, 2024.

Media contact:
Polly Manuel | 205.970.5912
media@encompasshealth.com

Investor Relations contact:
Mark Miller | 205.970.5860
Mark.Miller@encompasshealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-issues-notice-for-partial-redemption-of-its-5-75-senior-notes-due-2025--302283764.html

SOURCE Encompass Health Corp.

FAQ

What is the amount of Encompass Health's (EHC) partial redemption of 5.75% senior notes due 2025?

Encompass Health (EHC) is redeeming $100 million of the outstanding principal balance of its 5.75% senior notes due 2025.

When is the redemption date for Encompass Health's (EHC) partial redemption of 2025 notes?

The redemption date for Encompass Health's (EHC) partial redemption of the 2025 notes is set for November 21, 2024.

What is the redemption price for Encompass Health's (EHC) partial redemption of 2025 notes?

The redemption price for Encompass Health's (EHC) partial redemption of 2025 notes is 100.0% of par, plus accrued and unpaid interest.

How will Encompass Health (EHC) fund the partial redemption of its 2025 notes?

Encompass Health (EHC) plans to use cash on hand to fund the partial redemption of its 2025 notes.

What financial impact does Encompass Health (EHC) expect from the partial redemption of 2025 notes?

Encompass Health (EHC) expects to record an approximate $0.2 million loss on early extinguishment of debt in the fourth quarter of 2024 due to the partial redemption.